Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$124,710,718
+$2,688,521 QoQ
Shares Held
987,104
+12.7% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#123
of 2,275 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. GILD ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,710,718 | 987,104 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $122,022,197 | 875,527 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $81,707,035 | 665,692 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $79,394,526 | 715,266 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,164,349 | 515,598 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $40,849,843 | 364,568 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,151,576 | 12,467 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,425,115 | 40,853 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,677,985 | 39,032 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $308,968 | 4,218 | Shares | Defined | 2024-05-13 | |
| 2023-06-30 | $6,680,119 | 86,676 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,069,110 | 133,411 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $15,002,373 | 174,751 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,658,556 | 156,566 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,584,039 | 90,342 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,234,147 | 71,222 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,661,214 | 380,956 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,190,262 | 518,114 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $38,606,151 | 560,647 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $35,211,069 | 544,810 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $16,778 | 288 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $42,652 | 675 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $30,417,150 | 395,336 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $56,891 | 761 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||